Home NDC 65862-563 Olanzapine
Product NDC 65862-563
11-digit product format 658620563
Labeler code 65862
Product ID 65862-563_e10b90de-4a0a-413e-a5f9-6978a183b568
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Olanzapine
Dosage form TABLET
Route ORAL
Labeler Aurobindo Pharma Limited
Application ANDA202050
Marketing category ANDA
Marketing start 2012-04-23
Substance OLANZAPINE
Active strength 7.5 mg/1
Pharmacologic classes Atypical Antipsychotic [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes NDC auxiliary status# These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
Current NDC status page 1 of 1 · 2 matching rows.
Dataset, Scope, Product NDC table Dataset Scope Product NDC Package NDC Code Status Reporting period Source date unfinished product product 65862-563 UNFINISHED Active or certified unfinished drug listing 2026-10-05 unfinished package package 65862-563 65862-563-55 UNFINISHED Active or certified unfinished drug listing 2026-10-05
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 42 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 21:27 UTC · source 2025-12-05 unfinished product product a6255e0c9aa5…a0211a219f2e…2025-12-14 21:27 UTC · source 2025-12-05 unfinished package package 65862-563-55 a6255e0c9aa5…a0211a219f2e…2025-08-26 23:59 UTC · source 2025-08-26 unfinished product product 1d862106b807…00c93037cd84…2025-08-26 23:59 UTC · source 2025-08-26 unfinished package package 65862-563-55 1d862106b807…00c93037cd84…2025-05-15 14:59 UTC · source 2025-05-14 unfinished product product 390b4c401c3f…2c692c2daee3…2025-05-15 14:59 UTC · source 2025-05-14 unfinished package package 65862-563-55 390b4c401c3f…2c692c2daee3…2025-04-01 07:37 UTC · source 2025-03-31 unfinished product product e30019b0c005…a3f0b14938b7…2025-04-01 07:37 UTC · source 2025-03-31 unfinished package package 65862-563-55 e30019b0c005…a3f0b14938b7…2025-03-01 13:19 UTC · source 2025-02-28 unfinished product product bbbc9f937eca…946b9c97cf81…2025-03-01 13:19 UTC · source 2025-02-28 unfinished package package 65862-563-55 bbbc9f937eca…946b9c97cf81…2025-02-27 05:24 UTC · source 2025-02-26 unfinished product product f268b84574a6…26285f5ac5df…2025-02-27 05:24 UTC · source 2025-02-26 unfinished package package 65862-563-55 f268b84574a6…26285f5ac5df…2025-02-01 13:13 UTC · source 2025-01-31 unfinished product product f764e8902f78…92046438deef…2025-02-01 13:13 UTC · source 2025-01-31 unfinished package package 65862-563-55 f764e8902f78…92046438deef…2025-01-20 13:05 UTC · source 2025-01-17 unfinished product product 68b1e3bced9e…98a755eb8bc6…2025-01-20 13:05 UTC · source 2025-01-17 unfinished package package 65862-563-55 68b1e3bced9e…98a755eb8bc6…2024-11-29 20:42 UTC · source 2024-11-29 unfinished product product 05c55d027831…ca05dca9dc4c…2024-11-29 20:42 UTC · source 2024-11-29 unfinished package package 65862-563-55 05c55d027831…ca05dca9dc4c…2024-11-09 02:36 UTC · source 2024-11-08 unfinished product product 48b4f40e6753…c7c7a00d2afa…2024-11-09 02:36 UTC · source 2024-11-08 unfinished package package 65862-563-55 48b4f40e6753…c7c7a00d2afa…2024-10-09 02:27 UTC · source 2024-10-08 unfinished product product 27f29a85d7e4…1372111e901f…2024-10-09 02:27 UTC · source 2024-10-08 unfinished package package 65862-563-55 27f29a85d7e4…1372111e901f…2024-07-10 04:00 UTC · source 2024-07-09 unfinished product product 8d62ce987f31…9fe9ef23e30d…2024-07-10 04:00 UTC · source 2024-07-09 unfinished package package 65862-563-55 8d62ce987f31…9fe9ef23e30d…2024-05-28 21:11 UTC · source 2024-05-28 unfinished product product d1e113ab4d42…063ee3eb0a1d…2024-05-28 21:11 UTC · source 2024-05-28 unfinished package package 65862-563-55 d1e113ab4d42…063ee3eb0a1d…2024-05-15 03:51 UTC · source 2024-05-14 unfinished product product 50b4072663b7…eae3003ed65e…2024-05-15 03:51 UTC · source 2024-05-14 unfinished package package 65862-563-55 50b4072663b7…eae3003ed65e…2022-04-09 23:13 UTC · source 2022-04-08 unfinished product product 906f6e251498…bf70b80e44f0…2022-04-09 23:13 UTC · source 2022-04-08 unfinished package package 65862-563-55 906f6e251498…bf70b80e44f0…2021-12-27 23:28 UTC · source 2021-12-27 unfinished product product 6db9cb8d1e19…3449e1ec5b70…2021-12-27 23:28 UTC · source 2021-12-27 unfinished package package 65862-563-55 6db9cb8d1e19…3449e1ec5b70…2021-02-18 23:40 UTC · source 2021-02-18 unfinished product product 8fc7167e32ce…e96bbc724034…2021-02-18 23:40 UTC · source 2021-02-18 unfinished package package 65862-563-55 8fc7167e32ce…e96bbc724034…2020-12-18 03:04 UTC · source 2020-12-17 unfinished product product 4184dd79f89f…545327b3e20f…2020-12-18 03:04 UTC · source 2020-12-17 unfinished package package 65862-563-55 4184dd79f89f…545327b3e20f…2020-06-10 20:45 UTC · source 2020-06-10 unfinished product product 4bd3596a7b87…5c64c6f6865f…2020-06-10 20:45 UTC · source 2020-06-10 unfinished package package 65862-563-55 4bd3596a7b87…5c64c6f6865f…2019-12-08 06:16 UTC · source 2019-12-05 unfinished product product 263afe128892…91768de4ddbe…2019-12-08 06:16 UTC · source 2019-12-05 unfinished package package 65862-563-55 263afe128892…91768de4ddbe…2019-06-01 22:24 UTC · source 2019-05-30 unfinished product product 5b2001dcd8f5…54b53d4dc9e4…2019-06-01 22:24 UTC · source 2019-05-30 unfinished package package 65862-563-55 5b2001dcd8f5…54b53d4dc9e4…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 6 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A202050-001 OLANZAPINE OLANZAPINE 2.5MG TABLET / ORAL AB 2012-04-23 A202050-002 OLANZAPINE OLANZAPINE 5MG TABLET / ORAL AB 2012-04-23 A202050-003 OLANZAPINE OLANZAPINE 7.5MG TABLET / ORAL AB 2012-04-23 A202050-004 OLANZAPINE OLANZAPINE 10MG TABLET / ORAL AB 2012-04-23 A202050-005 OLANZAPINE OLANZAPINE 15MG TABLET / ORAL AB 2012-04-23 A202050-006 OLANZAPINE OLANZAPINE 20MG TABLET / ORAL AB 2012-04-23
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 6 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 7 · 258 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A202050-001 OLANZAPINE 2.5MG TABLET / ORAL AB 2012-04-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 A202050-002 OLANZAPINE 5MG TABLET / ORAL AB 2012-04-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 A202050-003 OLANZAPINE 7.5MG TABLET / ORAL AB 2012-04-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 A202050-004 OLANZAPINE 10MG TABLET / ORAL AB 2012-04-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 A202050-005 OLANZAPINE 15MG TABLET / ORAL AB 2012-04-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 A202050-006 OLANZAPINE 20MG TABLET / ORAL AB 2012-04-23 84e616aacf4f…2026-08-18 06:07:40 2026-07 A202050-001 OLANZAPINE 2.5MG TABLET / ORAL AB 2012-04-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A202050-002 OLANZAPINE 5MG TABLET / ORAL AB 2012-04-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A202050-003 OLANZAPINE 7.5MG TABLET / ORAL AB 2012-04-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A202050-004 OLANZAPINE 10MG TABLET / ORAL AB 2012-04-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A202050-005 OLANZAPINE 15MG TABLET / ORAL AB 2012-04-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A202050-006 OLANZAPINE 20MG TABLET / ORAL AB 2012-04-23 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A202050-001 OLANZAPINE 2.5MG TABLET / ORAL AB 2012-04-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A202050-002 OLANZAPINE 5MG TABLET / ORAL AB 2012-04-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A202050-003 OLANZAPINE 7.5MG TABLET / ORAL AB 2012-04-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A202050-004 OLANZAPINE 10MG TABLET / ORAL AB 2012-04-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A202050-005 OLANZAPINE 15MG TABLET / ORAL AB 2012-04-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A202050-006 OLANZAPINE 20MG TABLET / ORAL AB 2012-04-23 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202050-001 OLANZAPINE 2.5MG TABLET / ORAL AB 2012-04-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202050-002 OLANZAPINE 5MG TABLET / ORAL AB 2012-04-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202050-003 OLANZAPINE 7.5MG TABLET / ORAL AB 2012-04-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202050-004 OLANZAPINE 10MG TABLET / ORAL AB 2012-04-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202050-005 OLANZAPINE 15MG TABLET / ORAL AB 2012-04-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202050-006 OLANZAPINE 20MG TABLET / ORAL AB 2012-04-23 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A202050-001 OLANZAPINE 2.5MG TABLET / ORAL AB 2012-04-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A202050-002 OLANZAPINE 5MG TABLET / ORAL AB 2012-04-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A202050-003 OLANZAPINE 7.5MG TABLET / ORAL AB 2012-04-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A202050-004 OLANZAPINE 10MG TABLET / ORAL AB 2012-04-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A202050-005 OLANZAPINE 15MG TABLET / ORAL AB 2012-04-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A202050-006 OLANZAPINE 20MG TABLET / ORAL AB 2012-04-23 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202050-001 OLANZAPINE 2.5MG TABLET / ORAL AB 2012-04-23 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202050-002 OLANZAPINE 5MG TABLET / ORAL AB 2012-04-23 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202050-003 OLANZAPINE 7.5MG TABLET / ORAL AB 2012-04-23 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202050-004 OLANZAPINE 10MG TABLET / ORAL AB 2012-04-23 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202050-005 OLANZAPINE 15MG TABLET / ORAL AB 2012-04-23 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202050-006 OLANZAPINE 20MG TABLET / ORAL AB 2012-04-23 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A202050-001 OLANZAPINE 2.5MG TABLET / ORAL AB 2012-04-23 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A202050-002 OLANZAPINE 5MG TABLET / ORAL AB 2012-04-23 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A202050-003 OLANZAPINE 7.5MG TABLET / ORAL AB 2012-04-23 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A202050-004 OLANZAPINE 10MG TABLET / ORAL AB 2012-04-23 b8a1b40f171c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 7 · 258 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Olanzapine
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength OLANZAPINE 7.5 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination N7U69T4SZR Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 6 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 200034 Internal RxNorm lookup 283639 Internal RxNorm lookup 312077 Internal RxNorm lookup 312078 Internal RxNorm lookup 312079 Internal RxNorm lookup 314154 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# DailyMed Socrata Ingredients# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 65862-563 OLANZAPINE TABLET [AUROBINDO PHARMA LIMITED] 20 Current NDC, Legacy NDC, 6 package rows 20250306_636665be-9d7e-443a-8134-e8cc47e6ba24.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 65862-563-01 65862056301 100 TABLET in 1 BOTTLE (65862-563-01) 100 tablet 2012-04-23 0000-00-00 No No Current 65862-563-05 65862056305 500 TABLET in 1 BOTTLE (65862-563-05) 500 tablet 2012-04-23 0000-00-00 No No Current 65862-563-10 65862056310 10 BLISTER PACK in 1 CARTON (65862-563-10) / 10 TABLET in 1 BLISTER PACK 10 blister pack 2012-04-23 0000-00-00 No No Current 65862-563-30 65862056330 30 TABLET in 1 BOTTLE (65862-563-30) 30 tablet 2012-04-23 0000-00-00 No No Current 65862-563-55 65862056355 15000 TABLET in 1 BAG (65862-563-55) 15000 tablet 23-APR-12 Current 65862-563-99 65862056399 1000 TABLET in 1 BOTTLE (65862-563-99) 1000 tablet 2012-04-23 0000-00-00 No No Current